You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》據報內地AI醫療科企「推想醫療」最快今年在港上市籌3億美元
阿思達克 08-19 17:59
據《彭博通訊社》報道,高盛資產管理及啓明創投參投的內地人工智能醫療科技企業「推想醫療」,已委聘銀行協助在港上市事宜,集資或高達3億美元,最快今年上市。消息稱,推想醫療正與中信建投證券、高盛及瑞銀就潛在上市合作。 據官網介紹,推想醫療成立於2016年,專注於AI醫療領域,致力成爲全院級AI國際領軍品牌。公司採取「一橫一縱」和「國際化」戰略佈局打造立體化產品線,全面覆蓋肺部、心腦血管、乳腺、骨關節等多部位多臟器重大疾病,同時利用人工智能深度學習技術開發多個平臺,爲客戶提供「篩、診、治、管、研」醫療全流程智慧解決方案。 公司稱,作爲全球爲數不多的擁有美國FDA、歐盟CE、日本PMDA及中國NMPA四大市場準入的AI醫療科技公司,產品覆蓋全球近20個國家的400多家醫療機構;爲政府、醫療機構、醫生、患者提供先進的智慧醫療一體化服務。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account